Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationData Collection of Standard Care and Evaluation of NHLBI Patients and Donors
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 10,000
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT04450927 - Phase 2Taking peopleLarotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- Where
- Boston, Houston, Memphis, Philadelphia, San Francisco, Seattle
- Age
- 2 years to 99 years
- People
- 13
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT05783323 - No phaseTaking peopleLCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients
- Where
- Charlotte, Winston-Salem
- People
- 300
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06958107 - Phase 1Taking peoplePhase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
- Where
- Bethesda
- Age
- 3 years to 35 years
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06995872 - Phase 3Taking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Chapel Hill, Duarte, Farmington, Goodyear, Greenville, Houston, Indianapolis, Morristown, Providence, Shreveport, Tampa
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - No phaseTaking peopleLong-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- Where
- Akron, Albany, Albuquerque, Allentown, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bethesda, Bethlehem, Birmingham, Boise, Boston, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Madera, Madison, Marshfield, Maywood, Memphis, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morristown, Nashville, Newark, New Brunswick, New Haven, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Orange, Orlando, Palo Alto, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Summit, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Tulsa, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winston-Salem
- People
- 25,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT00736749 - Phase 2Taking peopleGraft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Where
- Pittsburgh, Seattle, Tampa
- Age
- 1 year to 60 years
- People
- 120
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03970096 - No phaseTaking peopleAndrogen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
- Where
- Bethesda
- Age
- 8 years to 99 years
- People
- 650
- Run by
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
See details and how to joinNCT04708431 - No phaseTaking peopleBrain MRF in Children, Adolescents and Young Adults With Acute Leukemia
- Where
- Cleveland
- Age
- Up to 30 years
- People
- 20
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06421155 - Phase 3Not yet taking people in United StatesComparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
- Where
- Birmingham, Columbus
- Age
- Up to 5 years
- People
- 96 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT07291102 · EU 2024-517133-40-00 - Phase 1/2Taking peopleA Study of Revumenib and Mezigdomide in People With Leukemia
- Where
- Basking Ridge, Chapel Hill, Commack, Duarte, Harrison, Houston, Middletown, Montvale, New York, Rockville Centre
- Age
- 12 years and over
- People
- 52
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07356154 - No phaseTaking peopleAn Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- Where
- Bethesda
- Age
- 2 years to 70 years
- People
- 2,000
- Run by
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
See details and how to joinNCT00001595 - Phase 3Taking peopleA Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Where
- Atlanta, Baltimore, Boston, Chapel Hill, Charleston, Charlotte, Chicago, Cleveland, Columbus, Dallas, Duarte, Durham, Gainesville, Houston, La Jolla, Loma Linda, Los Angeles, Maywood, Memphis, Miami, Milwaukee, Nashville, New Haven, New York, Philadelphia, Pittsburgh, Portland, Sacramento, St Louis, The Bronx, Washington D.C.
- People
- 115 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT03394365 · EU 2024-516622-57-00 - No phaseTaking peopleIntraoperative OCT Guidance of Intraocular Surgery II
- Where
- Durham
- Age
- 4 weeks and over
- People
- 262
- Run by
- Duke University
See details and how to joinNCT03713268 - No phaseTaking peopleBiology of Young Lung Cancer Study: The YOUNG LUNG Study
- Where
- Boston
- Age
- 15 years and over
- People
- 500
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT05265429 - Phase 1Taking peopleRevumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- Where
- Duarte
- Age
- 2 years and over
- People
- 27
- Run by
- City of Hope Medical Center
See details and how to joinNCT06575296 - Phase 1Taking peopleTegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
- Where
- Atlanta, Houston
- Age
- 1 year to 30 years
- People
- 24
- Run by
- Emory University
See details and how to joinNCT07144254 - No phaseTaking peopleNatural History Study of Patients With Neurofibromatosis Type 2
- Where
- Bethesda
- Age
- 8 years to 75 years
- People
- 269
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT00598351 - No phaseTaking peopleComprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
- Where
- Bethesda, Charlotte, New York, Orange, Washington D.C.
- Age
- 4 weeks and over
- People
- 6,035
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01109394 - No phaseTaking peopleCollection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- Where
- Bethesda
- Age
- 3 years and over
- People
- 1,100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01441089 - Phase 2Taking peopleNatural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- Where
- Bethesda
- Age
- 12 years and over
- People
- 740
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04074135 - No phaseTaking peopleFrequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Where
- Columbus
- People
- 500
- Run by
- Mohamed Abdel-Rahman
See details and how to joinNCT04792463 - No phaseTaking peopleComprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
- Where
- Bethesda
- Age
- 1 day to 120 years
- People
- 1,100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05350748 - No phaseTaking peopleA Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
- Where
- Bethesda, Washington D.C.
- Age
- 1 year to 120 years
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06507748 - Phase 1Taking peopleFGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
- Where
- Bethesda
- Age
- 3 years to 39 years
- People
- 50
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06865664